跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,116 条关于
“SURPASS-3”
全部
36,116
临床试验
17,761
药物
4,654
机构
1,358
资讯
12,343
去年
Tirzepatide Shows Favorable Muscle Composition Changes in Type 2 Diabetes Patients, SURPASS-3 Trial Analysis Reveals
去年
Adaptimmune Outlines New Strategy Amid Tecelra Launch
去年
Adaptimmune's Lete-cel Shows Promise in Sarcoma, Nearing FDA Submission
2个月前
Celea Therapeutics Secures $180 Million to Launch First Head-to-Head Phase 3 Trial of Deupirfenidone in IPF
2年前
Tirzepatide Shows Promise in Reducing Diabetes Risk and Outperforming Insulin
去年
Lancet Commission Charts Global Roadmap to Transform Breast Cancer Care and Address Health Inequities
去年
Teva Unveils $5 Billion Growth Strategy with Five Potential Blockbuster Drugs in Late-Stage Pipeline
去年
Medical Care Technologies Develops Patent-Pending AI Platform for Smartphone-Based Health Screening
2个月前
Biomarker-Based Immunoassays Market Poised to Reach $11.55 Billion by 2030, Driven by AI Integration and Rising Cancer Incidence
去年
Ropeginterferon Alfa-2b Shows Promise in Phase 3 Trial for Essential Thrombocythemia
第 1 页,共 1235 页
上一页
下一页